Related Experiment Video
Updated: Jan 17, 2026

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery
Published on: September 26, 2025
Ionic liquid-based transdermal drug delivery systems for biopharmaceuticals
Fahmida Habib Nabila1, Muhammad Moniruzzaman2, Masahiro Goto1,3,4
1Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan. m-goto@mail.cstm.kyushu-u.ac.jp.
Ionic liquids (ILs) enhance transdermal drug delivery (TDDS) of biologics like proteins and nucleic acids by improving skin permeation. IL-based nanocarrier systems show promise for treating diabetes and cancer via non-invasive delivery.
Area of Science:
- Biomedical Engineering
- Materials Science
- Pharmaceutical Sciences
Background:
- Transdermal delivery of biopharmaceuticals faces challenges due to the skin's stratum corneum barrier.
- Ionic liquids (ILs) offer unique physicochemical properties beneficial for drug delivery.
- ILs can act as solvents and permeation enhancers, improving biomolecule solubility, stability, and skin transport.
Purpose of the Study:
- To review recent advances in ionic liquid-based transdermal drug delivery systems (IL-TDDS).
- To highlight the application of ILs in nanocarrier systems for delivering biologics.
- To focus on lipid- and choline-derived IL-enabled TDDS.
Main Methods:
- Integration of ILs into various nanocarrier systems (ethosomes, transethosomes, emulsions, dispersions).
- Utilizing ILs as multifunctional materials for enhanced transdermal transport.
- Evaluating IL-TDDS efficacy in preclinical models for diabetes and cancer immunotherapy.
Main Results:
- Successful transdermal delivery of insulin, siRNA, mRNA, and other biologics using IL-based nanocarriers.
- IL-based formulations demonstrate high stability and enhanced drug bioavailability compared to conventional systems.
- Demonstrated prolonged glycemic control in diabetic models and potent anti-tumor responses in nucleic-acid immunotherapy.
Conclusions:
- Ionic liquids are effective multifunctional materials for overcoming transdermal delivery barriers.
- IL-enabled nanocarrier systems represent a promising strategy for non-invasive delivery of biopharmaceuticals.
- IL-TDDS holds significant potential for therapeutic applications in metabolic diseases and cancer immunotherapy.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.

